Literature DB >> 29727620

SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation.

Chi Kwan Tsang1, Miao Chen2, Xin Cheng3, Yanmei Qi3, Yin Chen2, Ishani Das3, Xiaoxing Li2, Brinda Vallat4, Li-Wu Fu2, Chao-Nan Qian2, Hui-Yun Wang5, Eileen White6, Stephen K Burley7, X F Steven Zheng8.   

Abstract

Nutrients are not only organic compounds fueling bioenergetics and biosynthesis, but also key chemical signals controlling growth and metabolism. Nutrients enormously impact the production of reactive oxygen species (ROS), which play essential roles in normal physiology and diseases. How nutrient signaling is integrated with redox regulation is an interesting, but not fully understood, question. Herein, we report that superoxide dismutase 1 (SOD1) is a conserved component of the mechanistic target of rapamycin complex 1 (mTORC1) nutrient signaling. mTORC1 regulates SOD1 activity through reversible phosphorylation at S39 in yeast and T40 in humans in response to nutrients, which moderates ROS level and prevents oxidative DNA damage. We further show that SOD1 activation enhances cancer cell survival and tumor formation in the ischemic tumor microenvironment and protects against the chemotherapeutic agent cisplatin. Collectively, these findings identify a conserved mechanism by which eukaryotes dynamically regulate redox homeostasis in response to changing nutrient conditions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Warburg; cancer; cisplatin; ischemia; mTOR; nutrient; rapamycin; reactive oxygen species; redox; superoxide dismutase 1

Mesh:

Substances:

Year:  2018        PMID: 29727620      PMCID: PMC6108545          DOI: 10.1016/j.molcel.2018.03.029

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  57 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Nutrient regulates Tor1 nuclear localization and association with rDNA promoter.

Authors:  Hong Li; Chi Kwan Tsang; Marcus Watkins; Paula G Bertram; X F Steven Zheng
Journal:  Nature       Date:  2006-08-09       Impact factor: 49.962

3.  Convergence of TOR-nitrogen and Snf1-glucose signaling pathways onto Gln3.

Authors:  Paula G Bertram; Jae H Choi; John Carvalho; Ting-Fung Chan; Wandong Ai; X F Steven Zheng
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 4.  Nutritional control of growth and development in yeast.

Authors:  James R Broach
Journal:  Genetics       Date:  2012-09       Impact factor: 4.562

5.  TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.

Authors:  X F Zheng; D Florentino; J Chen; G R Crabtree; S L Schreiber
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

6.  Rab1A is an mTORC1 activator and a colorectal oncogene.

Authors:  Janice D Thomas; Yan-Jie Zhang; Yue-Hua Wei; Jun-Hung Cho; Laura E Morris; Hui-Yun Wang; X F Steven Zheng
Journal:  Cancer Cell       Date:  2014-10-23       Impact factor: 31.743

Review 7.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 8.  ROS-dependent signal transduction.

Authors:  Colleen R Reczek; Navdeep S Chandel
Journal:  Curr Opin Cell Biol       Date:  2014-10-08       Impact factor: 8.382

Review 9.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis.

Authors:  Benoît D'Autréaux; Michel B Toledano
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

Review 10.  Signal transduction by reactive oxygen species.

Authors:  Toren Finkel
Journal:  J Cell Biol       Date:  2011-07-11       Impact factor: 10.539

View more
  35 in total

1.  N-Acetyl-L-Cysteine Reduces Fibrosis and Improves Muscle Function After Acute Compartment Syndrome Injury.

Authors:  Benyam Yosef; Yu Zhou; Kathryn Mouschouris; James Poteracki; Shay Soker; Tracy Criswell
Journal:  Mil Med       Date:  2020-01-07       Impact factor: 1.437

Review 2.  mTOR in Lung Neoplasms.

Authors:  Ildiko Krencz; Anna Sebestyen; Andras Khoor
Journal:  Pathol Oncol Res       Date:  2020-02-03       Impact factor: 3.201

Review 3.  Cross talk between SOD1 and the mitochondrial UPR in cancer and neurodegeneration.

Authors:  Maria Gomez; Doris Germain
Journal:  Mol Cell Neurosci       Date:  2019-04-24       Impact factor: 4.314

Review 4.  SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells.

Authors:  Caterina Peggion; Valeria Scalcon; Maria Lina Massimino; Kelly Nies; Raffaele Lopreiato; Maria Pia Rigobello; Alessandro Bertoli
Journal:  Antioxidants (Basel)       Date:  2022-03-23

5.  Exposure to perfluorooctanoic acid leads to promotion of pancreatic cancer.

Authors:  Lisa M Kamendulis; Jessica M Hocevar; Mikayla Stephens; George E Sandusky; Barbara A Hocevar
Journal:  Carcinogenesis       Date:  2022-06-04       Impact factor: 4.741

6.  Simultaneous loss of TSC1 and DEPDC5 in skeletal and cardiac muscles produces early-onset myopathy and cardiac dysfunction associated with oxidative damage and SQSTM1/p62 accumulation.

Authors:  Chun-Seok Cho; Yongsung Kim; Sung-Rye Park; Boyoung Kim; Carol Davis; Irene Hwang; Susan V Brooks; Jun Hee Lee; Myungjin Kim
Journal:  Autophagy       Date:  2021-12-29       Impact factor: 13.391

7.  ΜicroRNA-122 protects against ischemic stroke by targeting Maf1.

Authors:  Mengmeng Wang; Xiaoman Liu; Yu Wu; Yi Wang; Jiahui Cui; Jing Sun; Ying Bai; Ming-Fei Lang
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

Review 8.  The complex network of mTOR signalling in the heart.

Authors:  Sebastiano Sciarretta; Maurizio Forte; Giacomo Frati; Junichi Sadoshima
Journal:  Cardiovasc Res       Date:  2022-01-29       Impact factor: 10.787

9.  SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-β oligomers.

Authors:  Andrés Norambuena; Xuehan Sun; Horst Wallrabe; Ruofan Cao; Naidi Sun; Evelyn Pardo; Nutan Shivange; Dora Bigler Wang; Lisa A Post; Heather A Ferris; Song Hu; Ammasi Periasamy; George S Bloom
Journal:  Neurobiol Dis       Date:  2022-04-20       Impact factor: 7.046

10.  Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival, and Metastasis of Hepatocellular Carcinoma.

Authors:  Chao Jiang; Rui Xu; Xiao-Xing Li; Yu-Feng Zhou; Xiao-Yi Xu; Yang Yang; Hui-Yun Wang; X F Steven Zheng
Journal:  Mol Cancer Ther       Date:  2018-09-17       Impact factor: 6.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.